Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Marconi who wrote (2041)	7/13/1999 4:53:00 PM
From: Jim Roof	Read Replies (2) \| Respond to of 10293

m, Not to burst your bubble but the heaviest of the heavies is in Biotime's corner, Abbott Labs and they begin their marketing starting about... right now. There are also numerous patents which served at least well enough to convince Abbott to sign on with Biotime rather than go it alone. BTW, Abbott, if my memory serves me, already owns half of the old hetastarch market so by default Hextend should cannibalize half of the market - but at somewhat of a premium, thus not only expanding the blood of those in need but the dollar size of the market as well. But, please feel free to short as much as you can get your hands on. With close to 3MM shares officially short and no insider selling and a small float there will certainly be movement in the price. Finally, 8 7/8 is higher than 5 3/8. It looks to me like we may see a higher high since we are coming off of a higher low. It's going to be fun regardless.